Liver Function Abnormalities in Patients With Acute Heart Failure

ConditionAcute Heart Failure

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-90

SponsorSohag University

About this trial

The aim of this study is to evaluate liver function test abnormalities and to identify associated cardiac and non cardiac factors mediating hepatic impairment in acute heart failure patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients aged 18 yrs or older presenting with AHF

Disqualifiers

Congenital heart disease

acute and chronic liver diseases

Trial population

patients aged 18 yrs or older presenting with AHF

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Avoiding the risk factors
Behavioral
Exercise, Salt and lipid reduction in diet, smoking cessation

Treatment groups

100 Participants

are divided into 5 treatment groups

Group A: Acute decompensated heart failure (de novo or as decompensation of chronic heart failure)1 intervention

Group B: Pulmonary edema1 intervention

Group C: Hypertensive acute heart failure1 intervention

Group D: cardiogenic shock1 intervention

Group E: Acute coronary syndrome complicated by heart failure1 intervention

Trial outcomes

Primary outcomes

Liver function abnormalities in patients with acute heart failure in Sohag University Hospitals

assessment the LFTs abnormalities and factors mediating hepatic impairment in patients with AHF

Time frame

baseline

Secondary outcomes

Liver function abnormalities in patients with acute heart failure in Sohag University Hospitals

assessment the LFTs abnormalities and factors mediating hepatic impairment in patients with AHF

Time frame

1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: